To verify this mechanism, we examined the phosphorylation levels of AMPKα1 and ACC, along with SREBP1 expression, in liver tissues from NAFLD mice treated with rhein. Here, PRKAA1 is linked to metabolic dysfunction-associated steatotic liver disease.